Viking Systems, a developer, manufacturer, and marketer of 3D and 2D visualization solutions for complex minimally invasive surgery, today posted its first-quarter results for the three months ended March 31, 2012.
Viking reports a 13 percent year-over-year increase in 2012 first-quarter revenues to $3.5 million, an increase of 61 percent compared to fourth quarter 2011 revenues.
Gross profit for the quarter was $959,000, an increase of 47 percent year-over-year, and an increase of 138 percent compared to the fourth quarter of 2011.
Net loss for the quarter was $401,000, compared with a loss of $446,000 in the first quarter of 2011 and a loss of $1.0 million in the fourth quarter of 2011.
Viking also provided a business update, noting that as of March 31, 2012, the company has sold a total of 90 of its 3DHD Vision Systems since the product was launched in the fourth quarter of 2010.
It sold seven clinical systems during the first quarter of 2012, bringing the total number of clinical systems sold in the U.S. to 11. The company also added two new distribution partners in the first quarter, Keir Surgical in Canada and Neo Medical Systems covering Belgium and Luxemburg.
“We are pleased to be able to report that the first quarter of 2012 was a record quarter for total sales and placements of our 3DHD Vision Systems. Both total 3DHD systems, and more importantly, placements of clinical systems, meaning non demonstration systems, were at record levels,” Jed Kennedy, president and CEO of Viking Systems stated in the press release. “While placement of demonstration systems is important in creating the selling infrastructure needed to place systems in hospitals, we believe we have reached the transition point where clinical systems sales will consistently exceed demo systems placements. We also believe that placement of clinical systems will help to stimulate demand from new customers as they come to see the benefits being realized by the early adopters of our technology.”
For more information visit www.vikingsystems.com
Let us hear your thoughts below: